| Current Price | $1.71 | Mkt Cap | $279.0M |
|---|---|---|---|
| Open | $1.71 | P/E Ratio | 0.00 |
| Prev. Close | $1.71 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.69 - $1.77 | Volume | 1,241,913 |
| 52-Wk Range | $0.61 - $3.68 | Avg. Daily Vol. | 2,826,297 |
| Current Price | $1.71 | Mkt Cap | $279.0M |
|---|---|---|---|
| Open | $1.71 | P/E Ratio | 0.00 |
| Prev. Close | $1.71 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.69 - $1.77 | Volume | 1,241,913 |
| 52-Wk Range | $0.61 - $3.68 | Avg. Daily Vol. | 2,826,297 |
The best Bull and Bear pitches based on recency and number of recommendations.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. 453M pe- div-. Pain killer in stage 3. Rev is just starting. All-stars 12/0
Read the most recent pitches from players about TRVN.
Recs
tomfoolme
(67.13)
Submitted: 2/10/2021 3:05:03 AM :
Start Price:
$2.92
NASDAQ:TRVN Score:
-46.37
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. 453M pe- div-. Pain killer in stage 3. Rev is just starting. All-stars 12/0
Recs
chellur
(< 20)
Submitted: 9/29/2020 8:37:32 PM :
Start Price:
$2.90
NASDAQ:TRVN Score:
-64.54
TRVN'S treatment has been given the go ahead for the management of acute pain in adults who require an intravenous opioid pain reliever. This will propel the stock much higher in the long term.
Recs
TMFZhiyuanSun
(40.20)
Submitted: 9/18/2020 1:15:29 AM :
Start Price:
$2.17
NASDAQ:TRVN Score:
-32.91
Commercialization of a favorable opioid drug.
Find the members with the highest scoring picks in TRVN.
MichaelDFS (97.99) Score: +123.44
The Score Leader is the player with the highest score across all their picks in TRVN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| MichaelDFS | 97.99 | 3/17/2020 |
|
1Y | $0.60 | +186.67% | +63.23% | +123.44 | 0 Comment | |
| NorteClub | 29.48 | 7/29/2020 |
|
5Y | $2.21 | -22.62% | +27.73% | +50.36 | 0 Comment | |
| superstar | 99.93 | 10/10/2018 |
|
5Y | $0.91 | +88.33% | +44.99% | +43.34 | 1 Comment | |
| AtlanticoClub | < 20 | 7/24/2020 |
|
5Y | $1.95 | -12.31% | +28.40% | +40.71 | 0 Comment | |
| Paco57 | 67.13 |
|
|
1Y | $1.19 | +43.70% | +43.82% | -0.12 | 0 Comment | |
| DharmaBum | < 20 | 3/31/2021 |
|
3M | $1.81 | -5.52% | +4.07% | -9.60 | 0 Comment | |
| rlevine99 | < 20 | 5/29/2020 |
|
5Y | $1.40 | +22.14% | +36.26% | -14.11 | 1 Comment | |
| PayrollGeek | 40.07 | 5/29/2020 |
|
3Y | $1.40 | +22.14% | +36.26% | -14.11 | 0 Comment | |
| WeRStellar | < 20 | 3/5/2021 |
|
5Y | $1.81 | -5.47% | +9.98% | -15.45 | 0 Comment | |
| TMFZhiyuanSun | 40.20 | 12/8/2020 |
|
5Y | $2.17 | -21.20% | +11.71% | -32.91 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
